Citations

Clear

112 citation(s) found for "Schaefer, PL".

A phase III randomized trial of two different dosing schedules of erythropoietin (EPO) in patients with cancer-associated anemia: North Central Cancer Treatment Group (NCCTG) Study N02C2
Molina, R, Sloan, Jeff A. , Nikcevich, Daniel A., Schaefer, Paul, Rowland, Kendrith M. , Dentchev, Todor, Tschetter, Loren K., Novotny, P. J., Loprinzi, Charles L. , Steensma, David P.

Mayo Clinic

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 8031-8031

10.1200/jco.2005.23.16_suppl.8031 Get It

A Large Multiethnic Genome-Wide Association Study of Prostate Cancer Identifies Novel Risk Variants and Substantial Ethnic Differences
Hoffmann, Thomas J. , Jorgenson, Eric , Habel, Laurel A. , Passarelli, Michael N. , Cario, Clinton L. , Emami, Nima C. , Chao, Chun , Ghai, Nirupa R. , Shan, Jun , Ranatunga, Dilrini K., Aaronson, David S., Presti, Joseph C. , Berndt, Sonja I. , McDonnell, Shannon K. , French, Amy J. , Schaid, Daniel J. , Thibodeau, Stephen N. , Freedman, Matthew L. , Mucci, Lorelei A. , Haiman, Christopher A. , Henderson, Brian E., Seminara, Daniela, Kvale, Mark , Schaefer, Catherine , Risch, Neil , Witte, John S. , Wang, Zhaoming , Van Den Eeden, Stephen K , Sakoda, Lori C. , Graff, Rebecca E. , Quesenberry, Charles P. , Wang, Zhaoming , Chanock, Stephen Jacob , Li, Qiyuan , Penney, Kathryn , Kwok, Pui–Yan , Wang, Zhaoming , McDonnell, Shannon K

Mayo Clinic

Cancer Discovery | June 2, 2015 | Volume: 5 | Issue: 8 | Pages: 878-891

10.1158/2159-8290.cd-15-0315 | PMID 26034056 Get It

Abstract A genome-wide association study (GWAS) of prostate cancer in Kaiser Permanente health plan members (7,783 cases, 38,595 controls; 80.3% non-Hispanic white, 4.9% African-American, 7.0% East Asian, and 7.8% Latino) revealed a new independent risk indel rs4646284 at the previously identified locus 6q25.3 that replicated in PEGASUS (N = 7,539) and the Multiethnic Cohort (N = 4,679) with an overall P = 1.0 × 10−19 (OR, 1.18). Across the 6q25.3 locus, rs4646284 exhibited the strongest association with expression of SLC22A1 (P = 1.3 × 10−23) and SLC22A3 (P = 3.2 × 10−52). At the known 19q13.33 locus, rs2659124 (P = 1.3 × 10−13; OR, 1.18) nominally replicated in PEGASUS. A risk score of 105 known risk SNPs was strongly associated with prostate cancer (P < 1.0 × 10−8). Comparing the highest to lowest risk score deciles, the OR was 6.22 for non-Hispanic whites, 5.82 for Latinos, 3.77 for African-Americans, and 3.38 for East Asians. In non-Hispanic whites, the 105 risk SNPs explained approximately 7.6% of disease heritability. The entire GWAS array explained approximately 33.4% of heritability, with a 4.3-fold enrichment within DNaseI hypersensitivity sites (P = 0.004). Significance: Taken together, our findings of independent risk variants, ethnic variation in existing SNP replication, and remaining unexplained heritability have important implications for further clarifying the genetic risk of prostate cancer. Our findings also suggest that there may be much promise in evaluating understudied variation, such as indels and ethnically diverse populations. Cancer Discov; 5(8); 878–91. ©2015 AACR. This article is highlighted in the In This Issue feature, p. 783
Abstract 5251: ASCL1 and RET expression define a clinically relevant subgroup of lung adenocarcinoma characterized by neuroendocrine differentiation
Kosari, Farhad , Aubry, Marie Christine, Kovtun, Irina V. , Klein, Janet L. Schaefer, Tomaszek, Sandra, Yang, Ping , Wigle, Dennis A. , Vasmatzis, George , Ida, Cristiane M. , Yang, Lin , Murphy, Stephen J.

Mayo Clinic

Cancer Research | May 1, 2015 | Volume: 74 | Issue: 19_Supplement | Pages: 5251-5251

10.1158/1538-7445.am2014-5251 Get It

Abstract ASCL1 is an important regulatory transcription factor in pulmonary neuroendocrine cell development, but its value as a biomarker of neuroendocrine differentiation in lung adenocarcinoma (AD) and as a potential prognostic biomarker remains unclear. We examined ASCL1expression in lung cancer samples of varied histologic subtype, clinical outcome, and smoking status and compared to expression of traditional neuroendocrine markers. ASCL1 mRNA expression was found almost exclusively in smokers with AD, in contrast to non-smokers. ASCL1 protein expression by immunohistochemistry (IHC) correlated best with synaptophysin compared to chromogranin and CD56/NCAM. Analysis of a compendium of 367 microarray-based gene expression profiles in stage I lung adenocarcinomas identified significantly higher expression levels of the RET oncogene in ASCL1 positive tumors (ASCL1+) compared to ASCL1- tumors (q-value < 10 - 9). High levels of RET expression in ASCL1+ but not in ASCL1- tumors was associated with significantly shorter overall survival in stage 1 (p = 0.007) and in all AD (p = 0.037). RET protein expression by IHC had an association with overall survival in the context of ASCL1 expression. In silico gene set analysis and in vitro experiments by ASCL1 shRNA in AD cells with high endogenous expression of ASCL1 and RET implicated ASCL1 as a potential upstream regulator of the RET oncogene. Also, silencing ASCL1 in AD cells markedly reduced cell growth and motility. These results suggest that ASCL1 and RET expression define a clinically relevant subgroup of approximately 10% of AD characterized by neuroendocrine differentiation. Citation Format: Farhad Kosari, Cristiane M. Ida, Marie Christine Aubry, Lin Yang, Irina V. Kovtun, Janet L. Schaefer Klein, Sandra C. Tomaszek, Stephen J. Murphy, Ping Yang, Dennis Wigle, George Vasmatzis. ASCL1 and RET expression define a clinically relevant subgroup of lung adenocarcinoma characterized by neuroendocrine differentiation. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 5251. doi:10.1158/1538-7445.AM2014-5251
Seroprevalence of Aquaporin-4–IgG in a Northern California Population Representative Cohort of Multiple Sclerosis
Pittock, Sean J. , Lennon, Vanda A. , Bakshi, Nandini, Shen, Ling, McKeon, Andrew , Quach, Hong , Briggs, Farren , Bernstein, Allan , Schaefer, Catherine , Barcellos, Lisa F. , Pittock, S J , McKeon, Andrew , Briggs, Farren Bs

Mayo Clinic

JAMA Neurology | September 1, 2014 | Volume: 71 | Issue: 11 | Pages: 1433

10.1001/jamaneurol.2014.1581 | PMID 25178362 Get It

Liver Enzyme Elevations Within 3 Months of Diagnosis of Inflammatory Bowel Disease and Likelihood of Liver Disease
Goyal, Alka , Hyams, J S, Lerer, Trudy, LeLeiko, Neal S. , Otley, Anthony , Rosh, Joel R. , Cabrera, José, Oliva‐Hemker, Maria , Mack, David R. , Rick, James, Pfefferkorn, Marian D., Carvalho, Ryan , Grossman, Andrew B., Hitch, Meredith C., Sudel, Boris , Saeed, Shehzad A. , Faubion, William A. , Schaefer, Marc , Markowitz, James , Keljo, David J., Griffiths, Anne Marie , Kappelman, Michael D. , Leleiko, Neal S

Mayo Clinic

Journal of Pediatric Gastroenterology and Nutrition | May 2, 2014 | Volume: 59 | Issue: 3 | Pages: 321-323

10.1097/mpg.0000000000000409 | PMID 24796799 Get It

ABSTRACTBackground:Inflammatory bowel disease–associated liver diseases (IBD‐LDs) include autoimmune hepatitis (AIH), primary sclerosing cholangitis (PSC), and an overlap syndrome. Prospective unbiased multicenter data regarding the frequency of IBD‐LD in patients with pediatric inflammatory bowel disease (IBD) are lacking. We examined early alanine aminotransferase (ALT) and γ‐glutamyl transpeptidase (GGT) elevations in children diagnosed as having IBD and assessed the likelihood of IBD‐LD.Methods:Data collected from the prospective observational Pediatric Inflammatory Bowel Disease Collaborative Research Group Registry enrolling children of age <16 years within 30 days of diagnosis. AIH, PSC, and overlap syndrome were diagnosed using local institutional criteria.Results:A total of 1569 subjects had liver enzymes available. Of the total, 757 had both ALT and GGT, 800 had ALT only (no GGT), and 12 had GGT only (no ALT). Overall, 29 of 1569 patients (1.8%) had IBD‐LD. IBD‐LD was diagnosed in 1 of 661 (0.15%) of patients with both ALT and GGT ≤ 50 IU/L compared with 21 of 42 (50%) of patients with both ALT and GGT > 50 (odds ratio 660, P < 0.0001). Of the 29 patients with IBD‐LD, 21 had PSC, 2 had AIH, and 6 had overlap syndrome. IBD‐LD was more common in patients with ulcerative colitis and IBD‐unclassified (indeterminate colitis) than in those with Crohn disease (4% vs 0.8%, respectively, P < 0.001).Conclusions:Elevation of both ALT and GGT within 90 days after the diagnosis of IBD is associated with a markedly increased likelihood of IBD‐LD. Both ALT and GGT levels should be measured in all of the pediatric patients newly diagnosed as having IBD.
Kit Signaling Is Required for Development of Coordinated Motility Patterns in Zebrafish Gastrointestinal Tract
Rich, Adam , Gordon, Scott M. , Gibbons, Simon J. , Schaefer, Katherine L. , Hennig, Grant W. , Farrugia, Gianrico , Brown, Christopher James , Gibbons, S J

Mayo Clinic

Zebrafish | January 8, 2013 | Volume: 10 | Issue: 2 | Pages: 154-160

10.1089/zeb.2012.0766 | PMID 23297728 Get It

Focal malformations of cortical development
Bautista, Jocelyn F., Andermann, Frédérick, Cascino, G. D., Spencer, Susan S., Foldvary‐Schaefer, Nancy

Mayo Clinic

Neurology | May 13, 2012 | Volume: 62 | Issue: 6_suppl_3 | Pages: No page available

10.1212/01.wnl.0000115335.53381.2d | PMID 15037673 Get It

Genetic analysis of aquaporin-4 in neuromyelitis optica
Matiello, Marcelo , Schaefer-Klein, Janet, Hebrink, David D., Kingsbury, D., Atkinson, Elizabeth J. , Weinshenker, Brian G. , Weinshenker, Brian G

Mayo Clinic

Neurology | September 8, 2011 | Volume: 77 | Issue: 12 | Pages: 1149-1155

10.1212/wnl.0b013e31822f045b | PMID 21900637 Get It

Association of IL2RA p olymorphisms with susceptibility to multiple sclerosis is not explained by missense mutations in IL2RA
Matiello, Marcelo , Weinshenker, Brian G. , Atkinson, Elizabeth J. , Schaefer-Klein, Janet, Kantarci, Orhun H. , Weinshenker, Brian G

Mayo Clinic

Multiple Sclerosis Journal | January 14, 2011 | Volume: 17 | Issue: 5 | Pages: 634-636

10.1177/1352458510394703 | PMID 21239413 Get It

Genome-wide association studies have identified an association between two intronic single nucleotide polymorphisms (SNPs), rs12722489 and rs2104286, in the interleukin-2 receptor alpha-chain gene ( IL2RA) and susceptibility to multiple sclerosis (MS). We studied these SNPs in association with susceptibility to and severity of MS in a population-based cohort of 220 patients from Olmsted County, Minnesota, compared with 442 matched controls. We sequenced the exons, splice sites and 5’ and 3’ untranslated regions in 27 randomly selected MS patients (powered for allele frequency ≥0.04) to search for mutations. No novel missense mutation was identified. Two patients (7.5%) had an exon 2 SNP ( rs4308625) and two patients had an exon 4 SNP ( rs2228149), both synonymous.